U.S. Hospitality Stock News

In the past week, Terex Corporation reported first-quarter 2026 results showing sales of US$1,734 million versus US$1,229 million a year earlier, but a net loss of US$89 million driven largely by merger-related accounting and amortization charges tied to the REV Group acquisition. Management reaffirmed full-year 2026 guidance for net sales of US$7.50 billion to US$8.10 billion and highlighted progress on integrating REV Group into a new Specialty Vehicles segment, with targeted cost and...

Pebblebrook Hotel Trust reported first-quarter 2026 results showing revenue of US$345.66 million and a net loss of US$19.27 million, both improved from a year earlier. The company paired these results with a wide full-year 2026 outlook ranging from a US$6.00 million net loss to a US$6.00 million net profit, underlining both progress and uncertainty. Next, we’ll examine how the improved first-quarter loss and raised full-year guidance shape Pebblebrook’s existing investment narrative. We've...

Recently, CG Oncology, Inc. was upgraded to a Zacks Rank #2 (Buy) following an upward trend in its earnings estimates, reflecting increased optimism about its earnings outlook. This shift in analyst sentiment highlights how changes in projected earnings can quickly reshape perceptions of a company’s underlying business strength. We’ll now examine how this analyst upgrade, driven by rising earnings estimates, influences CG Oncology’s broader investment narrative for investors. Outshine the...

In recent days, National HealthCare Corporation has drawn scrutiny after bearish commentary underscored risks from its 2026 rent reset, potential EBITDA compression, and operational headwinds including staffing pressures, quality concerns, and reimbursement challenges. This critique, set against governance shifts and activist pressure at key landlord National Health Investors, raises fresh questions about the resilience of NHC’s traditional skilled-nursing–centric model. Against this...

Alignment Healthcare (ALHC) just reported a profitable first quarter, with revenue of US$1,235.2 million, net income of US$11.42 million, and earnings per share ahead of expectations, while also raising its full-year revenue guidance. See our latest analysis for Alignment Healthcare. Despite the strong first quarter profit and higher full year guidance, Alignment Healthcare’s recent share price has been volatile, with a 1 day share price return of a 10.12% decline but a 1 year total...

Why Copart is on investors’ radar today Copart (CPRT) is drawing attention after a period in which the stock shows a 16.15% decline over the past 3 months and a 45.66% decline over the past year. This recent performance is prompting closer scrutiny of its underlying business. See our latest analysis for Copart. Despite a modest 0.6% 7 day share price return at around US$33.27, Copart’s recent 3 month share price return of negative 16.15% and 1 year total shareholder return of negative 45.66%...

Ocular Therapeutix (OCUL) is back in focus after enrolling the first patient in its SOL-X long-term extension trial for AXPAXLI in wet age-related macular degeneration, alongside ongoing FDA discussions and New Drug Application preparations. See our latest analysis for Ocular Therapeutix. Despite the steady flow of clinical and regulatory updates around AXPAXLI, Ocular Therapeutix’s share price has been volatile, with an 11.07% 1 month share price return at a latest share price of US$9.43, a...

D.R. Horton (DHI) is back in focus after its latest quarterly update, which combined softer year over year earnings, a trimmed yet still higher full year revenue outlook, and ongoing pressure from housing affordability. See our latest analysis for D.R. Horton. The share price has been under pressure in the short term, with a 1 day share price return of a 2.52% decline and a 7 day share price return of a 6.20% decline, even though the 1 year total shareholder return is 18.82%. This suggests...

Recent performance snapshot Fidelis Insurance Holdings (NYSE:FIHL) has drawn attention after a recent stretch of positive share performance, with the stock up over the past week, month, and past 3 months, and closing at US$21.21. See our latest analysis for Fidelis Insurance Holdings. That recent momentum fits into a stronger run for investors, with a 1 year total shareholder return of 31.39% alongside a 90 day share price return of 10.35%, suggesting sentiment has been improving. If this...

Oscar Health (OSCR) is drawing fresh attention after launching its Lucie Health Marketplace, an all-in-one storefront for individual and employer health benefits, as investors also look ahead to the company’s upcoming earnings report. See our latest analysis for Oscar Health. At a share price of $18.49, Oscar Health has seen strong recent momentum, with a 30 day share price return of 55.12% and a 1 year total shareholder return of 40.08%. This builds on a very large 3 year total shareholder...

In April 2026, Matador Resources Company promoted Christopher P. Calvert to Executive Vice President and Chief Financial Officer and Glenn W. Stetson to Executive Vice President and Chief Operating Officer, while its board also approved a quarterly cash dividend of US$0.375 per share payable on June 5, 2026. These leadership changes and continued cash returns to shareholders come as Matador faces softer earnings expectations and heightened sensitivity to global oil price movements driven by...

BofA Securities recently began covering Global Business Travel Group, Inc. with a neutral rating, while Citi reiterated a positive stance, both focusing on the company’s business model and technology positioning against newer competitors. Together, these differing analyst views highlight a tension between concerns over legacy booking infrastructure and confidence in Global Business Travel Group’s ongoing execution and service capabilities. We’ll now examine how BofA’s concerns about legacy...

Constellation Brands (STZ) is drawing attention after launching Modelo Chelada Suprema nationwide. It is the first high-ABV entry in the Modelo lineup and is directly targeting demand for stronger, flavor-forward ready-to-drink options among younger drinkers. See our latest analysis for Constellation Brands. Despite the buzz around Modelo Chelada Suprema, Constellation Brands' recent share price performance has been mixed, with a 1 month share price return of 1.07% and a year to date share...

In the past week, Colgate-Palmolive reported first-quarter 2026 results showing net sales rising to US$5,324 million from US$4,911 million a year earlier, while GAAP diluted earnings per share from continuing operations eased to US$0.80 from US$0.85. The company also reaffirmed its full-year 2026 sales outlook and expanded its multi-year Strategic Growth and Productivity Program, aiming for US$200 million to US$300 million in annualized savings mainly from 2027 and 2028 to help offset...

In April 2026, Masco Corporation reported higher first‑quarter 2026 sales of US$1,918 million and net income of US$213 million, maintained its full‑year earnings guidance, continued substantial share repurchases, and confirmed it is actively pursuing bolt‑on acquisitions. Alongside these results, Masco announced upcoming retirements and promotions that will concentrate leadership of its largest brands under the CEO, potentially reshaping procurement, supply chain efficiency, and long‑term...

In late April 2026, Gentex Corporation reported first‑quarter 2026 results showing higher sales and earnings year over year, raised its 2026 consolidated revenue guidance to between US$2.65 billion and US$2.75 billion, updated its 2027 revenue outlook to US$2.80 billion–US$2.90 billion, and completed a buyback of 7,437,692 shares. The combination of stronger quarterly performance, higher forward revenue expectations, and active share repurchases highlights Gentex’s focus on scaling its...

FMC Corporation recently reported past first-quarter 2026 results showing sales of US$758.6 million versus US$791.4 million a year earlier and a net loss of US$281.3 million, while its board maintained an US$0.08 quarterly dividend and amended its credit agreement to add new leverage covenants and collateral. Despite the deeper loss, FMC reaffirmed its full-year outlook, advanced a US$1.00 billion debt reduction plan, and continued progressing new crop protection ingredients, which together...

In the past few days, FirstSun Capital Bancorp reported first‑quarter 2026 results that fell short of analyst expectations as higher provisions for credit losses followed significant net charge‑offs tied to two commercial loans. Management also highlighted strong core profitability, healthy loan growth, and faster‑than‑planned cost synergies from the First Foundation acquisition, even as balance‑sheet repositioning weighs on near‑term margins. Next, we’ll examine how the spike in provisions...

In late April 2026, DiamondRock Hospitality’s board declared a regular quarterly cash dividend of US$0.09 per share and reported first-quarter results showing year-on-year growth in revenue and net income. The company also issued full-year 2026 net income guidance of US$106,850,000 to US$119,850,000 and signaled potential additional dividends tied to operating income, highlighting management’s confidence in its current operating and capital plans. Now we’ll examine how DiamondRock’s...

Buyback announcement and recent earnings put Dynex Capital in focus Dynex Capital (DX) has introduced a new buyback plan, authorizing up to US$300 million of share repurchases through April 30, 2028, shortly after reporting a first quarter net loss. See our latest analysis for Dynex Capital. At a share price of US$13.57, Dynex Capital has seen a 5.44% 1 month share price return. Its 1 year total shareholder return of 30.29% suggests investors who reinvested distributions have fared...

Roku (ROKU) is back in the spotlight after first quarter 2026 results showed a return to profitability, stronger platform economics, and record premium subscription momentum, prompting fresh questions about where the stock goes next. See our latest analysis for Roku. The earnings beat and raised outlook have been reflected in the recent 26.54% 1 month share price return and a very strong 1 year total shareholder return of 100.78%, even though the 5 year total shareholder return is still...

In April 2026, SkyWest, Inc. reported first-quarter 2026 results showing revenue of US$1,013.18 million and net income of US$101.69 million, with both basic and diluted earnings per share from continuing operations slightly higher than a year earlier. Over the same quarter, SkyWest repurchased 782,900 shares for US$75.3 million, completing a total buyback of 6,458,719 shares since May 2023, which may meaningfully affect per-share metrics and capital allocation views. We’ll now examine how...

In the past week, Eastman Chemical reported first-quarter 2026 results showing sales of US$2,177 million and net income of US$107 million, with both revenue and earnings lower than a year earlier but slightly ahead of adjusted profit expectations. At the same time, Eastman highlighted strong momentum in its circular Renew platform and specialty plastics, alongside aggressive price actions and the global launch of its new Saflex Evoca XIR.SR interlayer for electric-vehicle sunroofs,...

Why earnings expectations and a new Pacsun tie up matter for Formula One Group (FWON.K) Analysts recently lifted earnings estimates for Formula One Group (FWON.K) ahead of its 7 May 2026 report, and Pacsun’s latest FORMULA 1 MIAMI GRAND PRIX collection spotlights the brand’s reach with younger fans. See our latest analysis for Formula One Group. Despite the near term excitement around earnings and brand collaborations like the Pacsun Miami collection, Formula One Group’s share price return...